Literature DB >> 21925548

Response surface optimization of the heparosan N-deacetylation in producing bioengineered heparin.

Zhenyu Wang1, Jennifer Li, Samantha Cheong, Ujjwal Bhaskar, Onishi Akihiro, Fuming Zhang, Jonathan S Dordick, Robert J Linhardt.   

Abstract

The chemical step in the chemoenzymatic synthesis of bioengineered heparin has been examined and optimized statistically using a response surface methodology. A four factor, two level full factorial design experiment and a three factor Box-Behnken design were carried out. The goal was to establish a method to prepare N-sulfo, N-acetyl heparosan of the desired N-acetyl content, number average molecular weight, and in maximum yield by controlling the reactant concentrations, reaction time and reaction temperature. The response surface models obtained were used to predict the reaction conditions required to optimally prepare N-sulfo, N-acetyl heparosan from Escherichia coli generated heparosan starting material of different molecular weights.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21925548      PMCID: PMC3196266          DOI: 10.1016/j.jbiotec.2011.08.013

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  20 in total

1.  Combined quantitative (1)H and (13)C nuclear magnetic resonance spectroscopy for characterization of heparin preparations.

Authors:  M Guerrini; A Bisio; G Torri
Journal:  Semin Thromb Hemost       Date:  2001-10       Impact factor: 4.180

2.  Box-Behnken design: an alternative for the optimization of analytical methods.

Authors:  S L C Ferreira; R E Bruns; H S Ferreira; G D Matos; J M David; G C Brandão; E G P da Silva; L A Portugal; P S dos Reis; A S Souza; W N L dos Santos
Journal:  Anal Chim Acta       Date:  2007-07-23       Impact factor: 6.558

3.  Enhanced 2,3-butanediol production by Klebsiella pneumoniae SDM.

Authors:  Cuiqing Ma; Ailong Wang; Jiayang Qin; Lixiang Li; Xulu Ai; Tianyi Jiang; Hongzhi Tang; Ping Xu
Journal:  Appl Microbiol Biotechnol       Date:  2008-10-24       Impact factor: 4.813

4.  Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events.

Authors:  Marco Guerrini; Daniela Beccati; Zachary Shriver; Annamaria Naggi; Karthik Viswanathan; Antonella Bisio; Ishan Capila; Jonathan C Lansing; Sara Guglieri; Blair Fraser; Ali Al-Hakim; Nur Sibel Gunay; Zhenqing Zhang; Luke Robinson; Lucinda Buhse; Moheb Nasr; Janet Woodcock; Robert Langer; Ganesh Venkataraman; Robert J Linhardt; Benito Casu; Giangiacomo Torri; Ram Sasisekharan
Journal:  Nat Biotechnol       Date:  2008-04-23       Impact factor: 54.908

5.  Enzymatic redesigning of biologically active heparan sulfate.

Authors:  Jinghua Chen; Fikri Y Avci; Eva M Muñoz; Lynda M McDowell; Miao Chen; Lars C Pedersen; Lijuan Zhang; Robert J Linhardt; Jian Liu
Journal:  J Biol Chem       Date:  2005-10-31       Impact factor: 5.157

6.  Heparin-like compounds prepared by chemical modification of capsular polysaccharide from E. coli K5.

Authors:  B Casu; G Grazioli; N Razi; M Guerrini; A Naggi; G Torri; P Oreste; F Tursi; G Zoppetti; U Lindahl
Journal:  Carbohydr Res       Date:  1994-10-17       Impact factor: 2.104

7.  Solution structures of chemoenzymatically synthesized heparin and its precursors.

Authors:  Zhenqing Zhang; Scott A McCallum; Jin Xie; Lidia Nieto; Francisco Corzana; Jesús Jiménez-Barbero; Miao Chen; Jian Liu; Robert J Linhardt
Journal:  J Am Chem Soc       Date:  2008-09-04       Impact factor: 15.419

8.  Using an enzymatic combinatorial approach to identify anticoagulant heparan sulfate structures.

Authors:  Jinghua Chen; Courtney L Jones; Jian Liu
Journal:  Chem Biol       Date:  2007-09

Review 9.  Lessons learned from the contamination of heparin.

Authors:  Haiying Liu; Zhenqing Zhang; Robert J Linhardt
Journal:  Nat Prod Rep       Date:  2009-01-19       Impact factor: 13.423

10.  Enzymatic synthesis of antithrombin III-binding heparan sulfate pentasaccharide.

Authors:  Balagurunathan Kuberan; Miroslaw Z Lech; David L Beeler; Zhengliang L Wu; Robert D Rosenberg
Journal:  Nat Biotechnol       Date:  2003-10-05       Impact factor: 54.908

View more
  11 in total

1.  High cell density cultivation of a recombinant Escherichia coli strain expressing a 6-O-sulfotransferase for the production of bioengineered heparin.

Authors:  J Zhang; M Suflita; C M Fiaschetti; G Li; L Li; F Zhang; J S Dordick; R J Linhardt
Journal:  J Appl Microbiol       Date:  2014-12-02       Impact factor: 3.772

2.  Determination of epinephrine in pharmaceutical formulation by an optimized novel luminescence method using CdS quantum dots as sensitizer.

Authors:  Seyed Naser Azizi; Mohammad Javad Chaichi; Parmis Shakeri; Ahmadreza Bekhradnia
Journal:  J Fluoresc       Date:  2012-10-11       Impact factor: 2.217

Review 3.  Synthetic Oligosaccharide Libraries and Microarray Technology: A Powerful Combination for the Success of Current Glycosaminoglycan Interactomics.

Authors:  Vitor H Pomin; Xu Wang
Journal:  ChemMedChem       Date:  2017-12-06       Impact factor: 3.466

4.  A purification process for heparin and precursor polysaccharides using the pH responsive behavior of chitosan.

Authors:  Ujjwal Bhaskar; Anne M Hickey; Guoyun Li; Ruchir V Mundra; Fuming Zhang; Li Fu; Chao Cai; Zhimin Ou; Jonathan S Dordick; Robert J Linhardt
Journal:  Biotechnol Prog       Date:  2015-07-16

Review 5.  Advances in the preparation and synthesis of heparin and related products.

Authors:  Sultan N Baytas; Robert J Linhardt
Journal:  Drug Discov Today       Date:  2020-09-16       Impact factor: 7.851

6.  High cell density cultivation of a recombinant E. coli strain expressing a key enzyme in bioengineered heparin production.

Authors:  Odile Francesca Restaino; Ujjwal Bhaskar; Priscilla Paul; Lingyun Li; Mario De Rosa; Jonathan S Dordick; Robert J Linhardt
Journal:  Appl Microbiol Biotechnol       Date:  2013-01-15       Impact factor: 4.813

7.  N-sulfotestosteronan, a novel substrate for heparan sulfate 6-O-sulfotransferases and its analysis by oxidative degradation.

Authors:  Guoyun Li; Sayaka Masuko; Dixy E Green; Yongmei Xu; Lingyun Li; Fuming Zhang; Changhu Xue; Jian Liu; Paul L DeAngelis; Robert J Linhardt
Journal:  Biopolymers       Date:  2013-10       Impact factor: 2.505

Review 8.  Bioengineered heparins and heparan sulfates.

Authors:  Li Fu; Matthew Suflita; Robert J Linhardt
Journal:  Adv Drug Deliv Rev       Date:  2015-11-10       Impact factor: 15.470

9.  Optimization of Polyplex Formation between DNA Oligonucleotide and Poly(ʟ-Lysine): Experimental Study and Modeling Approach.

Authors:  Tudor Vasiliu; Corneliu Cojocaru; Alexandru Rotaru; Gabriela Pricope; Mariana Pinteala; Lilia Clima
Journal:  Int J Mol Sci       Date:  2017-06-17       Impact factor: 5.923

Review 10.  Engineered heparins as new anticoagulant drugs.

Authors:  Deepika Vaidyanathan; Asher Williams; Jonathan S Dordick; Mattheos A G Koffas; Robert J Linhardt
Journal:  Bioeng Transl Med       Date:  2016-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.